Oral Proteins & Peptides Market Research: Semaglutide, Linaclotide, Calcitonin,GLP-1 Receptor Agonist, GEP, CGRP, Diabetes, Gastroenterology, Genetic Disorder - Global Forecast to 2029 Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), Therapeutic...

Oral Proteins and Peptides Market Poised to Reach $2.67 Billion by 2028, Fueled by Aging Population and Technological Advancements Dublin, Sept. 15, 2023 (GLOBE NEWSWIRE) -- The "Oral Proteins and Peptides Market by Drug Type, Application, and Region 2023-2028" report has been added to ResearchAndMarkets.com's offering. The...

The oral proteins and peptides market is anticipated to grow at a CAGR of 20%, during 2022-2032, claims Roots Analysis London, June 15, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Oral Proteins and Peptides Market, 2022-2032” report to its list of offerings. Over the past few years,...